These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34593102)

  • 21. Mast Cell Disorders In Drug Hypersensitivity.
    Bonadonna P; Bonifacio M; Zanotti R
    Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug allergy in mastocytosis.
    Bonadonna P; Lombardo C
    Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.
    Gulen T
    Immunol Allergy Clin North Am; 2023 Nov; 43(4):681-698. PubMed ID: 37758406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?
    Golden DBK; Carter MC
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1117-1123. PubMed ID: 30961837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaphylaxis and mast cell disease: what is the risk?
    Akin C
    Curr Allergy Asthma Rep; 2010 Jan; 10(1):34-8. PubMed ID: 20425512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KIT and mastocytosis.
    Lim KH; Pardanani A; Tefferi A
    Acta Haematol; 2008; 119(4):194-8. PubMed ID: 18566536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
    Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
    Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, prognosis, and risk factors in mastocytosis.
    Brockow K
    Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.
    Sánchez-Muñoz L; Teodosio C; Morgado JM; Perbellini O; Mayado A; Alvarez-Twose I; Matito A; Jara-Acevedo M; García-Montero AC; Orfao A; Escribano L
    Immunol Allergy Clin North Am; 2014 May; 34(2):297-313. PubMed ID: 24745675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
    Kačar M; Rijavec M; Šelb J; Korošec P
    Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of mast cell clonality in patients with unexplained anaphylaxis.
    Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
    Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
    Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
    Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction.
    Valent P; Akin C
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1109-1114. PubMed ID: 30961836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis.
    Brockow K; Plata-Nazar K; Lange M; Nedoszytko B; Niedoszytko M; Valent P
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting c-kit in the therapy of mast cell disorders: current update.
    El-Agamy DS
    Eur J Pharmacol; 2012 Sep; 690(1-3):1-3. PubMed ID: 22789565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to interpret mast cell tests.
    Waterfield T; Dyer E; Wilson K; Boyle RJ
    Arch Dis Child Educ Pract Ed; 2016 Oct; 101(5):246-51. PubMed ID: 27325614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Clonality and Underlying Mastocytosis in Mast Cell Activation Syndromes.
    Gonzalez-de-Olano D; Álvarez-Twose I
    Curr Allergy Asthma Rep; 2024 Feb; 24(2):25-32. PubMed ID: 38270805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary alpha tryptasemia in identical twins.
    Bethea LH; Tuano KS; Seth N; Chinen J
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):503-504. PubMed ID: 34157394
    [No Abstract]   [Full Text] [Related]  

  • 39. Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KIT.
    Bibi S; Arock M
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):527-543. PubMed ID: 30007468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cell disorders and idiopathic anaphylaxis: Evaluation and management.
    Khalid MB; Lieberman P
    Allergy Asthma Proc; 2020 Mar; 41(2):90-98. PubMed ID: 32122445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.